Organicell Regenerative Medicine, Inc. – OTC:BPSR

Add to watchlist

$0.06

+0.02

+74.93%

Market closed

Open in about 4 hours

-43.33%

month

-43.33%

quarter

Market Cap	N/A
Enterprise value	66.66M

P/E	-2.4
EV/Sales	13.56
EV/EBITDA	-3.95
Price/Sales	13.45
Price/Book	-26.84
PEG ratio	0.01
EPS	-0.01

Revenue	4.91M
EBITDA	-16.84M
Income	-16.96M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	-345.15%
Oper. margin	-344.65%
Gross margin	88.99%
EBIT margin	-344.65%
EBITDA margin	-342.83%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Organicell Regenerative Medicine, Inc. (OTC:BPSR): Profit margin
Oct 2020	983.26K	-5.16M	-525.27%
Jan 2021	1.36M	-8.15M	-595.57%
Apr 2021	1.19M	-2.23M	-187.39%
Jul 2021	1.36M	-1.40M	-103%

Organicell Regenerative Medicine, Inc. (OTC:BPSR): Debt to assets
Oct 2020	1334172	2.72M	204.32%
Jan 2021	870925	3.74M	430.47%
Apr 2021	1308167	3.82M	292.52%
Jul 2021	1716188	4.17M	243.54%

Organicell Regenerative Medicine, Inc. (OTC:BPSR): Cash Flow
Jul 2020	-317.20K	-95.46K	475.43K
Oct 2020	-838.90K	0	1.11M
Apr 2021	-1.13M	0	1.26M
Jul 2021	-502.90K	-178.54K	515.44K

Organicell Regenerative Medicine alternative data

Organicell Regenerative Medicine
Employees

Organicell Regenerative Medicine, Inc. (OTC:BPSR): Employee count
Aug 2023	18
Sep 2023	18
Oct 2023	18
Nov 2023	18
Dec 2023	18
Jan 2024	18
Feb 2024	18
Mar 2024	18
Apr 2024	18
May 2024	18
Jun 2024	18
Jul 2024	18

Organicell Regenerative Medicine
Insider Trading

Organicell Regenerative Medicine, Inc. (OTC:BPSR): Insider trades (number of shares)
Period	Buy	Sel
Jul 2020	1166666	0
Aug 2020	422514	0
Oct 2020	625000	0
Dec 2020	2000000	0
Feb 2021	1818181	0
Apr 2021	0	300000
May 2021	0	4804878
Jun 2021	0	3529319

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	17 Jun 2021	MITRANI MARIA INES officer: Chief Science Officer officer: Chief Science Officer	Common Stock	44,772	$0.14	$6,179
Sale	17 Jun 2021	MITRANI MARIA INES officer: Chief Science Officer officer: Chief Science Officer	Common Stock	5,228	$0.14	$732
Sale	17 Jun 2021	SHAPIRO GEORGE CRAIG director, officer: Chief Medical Offi.. director, officer: Chief Medica..	Common Stock	9,955	$0.14	$1,374
Sale	17 Jun 2021	MITRANI ALBERT director, 10 percent owner, officer: Presid.. director, 10 percent owner, off..	Common Stock	50,000	$0.14	$7,000
Sale	17 Jun 2021	BOTHWELL IAN T director, 10 percent owner, officer: Chief .. director, 10 percent owner, off..	Common Stock	50,000	$0.14	$6,900
Sale	16 Jun 2021	MITRANI ALBERT director, 10 percent owner, officer: Presid.. director, 10 percent owner, off..	Common Stock	50,000	$0.16	$8,050
Sale	16 Jun 2021	MITRANI ALBERT director, 10 percent owner, officer: Presid.. director, 10 percent owner, off..	Common Stock	40,000	$0.15	$5,840
Sale	16 Jun 2021	SHAPIRO GEORGE CRAIG director, officer: Chief Medical Offi.. director, officer: Chief Medica..	Common Stock	40,375	$0.15	$6,177
Sale	16 Jun 2021	SHAPIRO GEORGE CRAIG director, officer: Chief Medical Offi.. director, officer: Chief Medica..	Common Stock	21,079	$0.15	$3,162
Sale	16 Jun 2021	MITRANI MARIA INES officer: Chief Science Officer officer: Chief Science Officer	Common Stock	50,000	$0.16	$8,050

BPSR insider trading transactions

Frequently Asked Questions (FAQ)

What's the price of Organicell Regenerative Medicine stock today?

One share of Organicell Regenerative Medicine stock can currently be purchased for approximately $0.06.
When is Organicell Regenerative Medicine's next earnings date?

Unfortunately, Organicell Regenerative Medicine's (BPSR) next earnings date is currently unknown.
Does Organicell Regenerative Medicine pay dividends?

No, Organicell Regenerative Medicine does not pay dividends.
What is Organicell Regenerative Medicine's stock symbol?

Organicell Regenerative Medicine, Inc. is traded on the OTC under the ticker symbol "BPSR".
What is Organicell Regenerative Medicine's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Organicell Regenerative Medicine?

Shares of Organicell Regenerative Medicine can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Organicell Regenerative Medicine have?

As Jul 2024, Organicell Regenerative Medicine employs 18 workers.
When Organicell Regenerative Medicine went public?

Organicell Regenerative Medicine, Inc. is publicly traded company for more then 3 years since IPO on 31 Jan 2022.
What is Organicell Regenerative Medicine's official website?

The official website for Organicell Regenerative Medicine is organicell.com.
Where are Organicell Regenerative Medicine's headquarters?

Organicell Regenerative Medicine is headquartered at 4045 Sheridan Avenue, Miami, FL.
How can i contact Organicell Regenerative Medicine?

Organicell Regenerative Medicine's mailing address is 4045 Sheridan Avenue, Miami, FL and company can be reached via phone at +888 9637881.

Organicell Regenerative Medicine, Inc.

organicell.com

Exchange:

OTC

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.

+888 9637881

4045 Sheridan Avenue
Miami, FL 33140

CIK: 0001557376
ISIN: US09074L1052
CUSIP: 09074L105